Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q2 EPS of ($0.29), $0.10 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $2.73 million versus the consensus estimate of $3.59 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.